Although genetic alterations of APC, Axin1 and β-catenin have been detected in clinical specimens of advanced prostate cancer [16], the interaction between Axin1 and Wnt/β-catenin pathway in affecting prostate cancer progression is poorly understood. Here, AXIN1 is linked to prostate carcinoma.